Documentation scienceplus.abes.fr version Bêta
AttributsValeurs
type
Is Part Of
Subject
Title
  • Timing of invasive treatment after fibrinolysis in ST elevation myocardial infarction - a meta-analysis of immediate or early routine versus deferred or ischemia-guided randomised controlled trials
has manifestation of work
related by
Abstract
  • Context. Controversy remains over the optimal timing of percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) who have initially been treated with fibrinolytic agents. Objective. A meta-analysis of studies was performed comparing immediate or early angiography after fibrinolysis versus a more conservative strategy of deferred PCI or ischaemia-guided management. Data sources. MEDLINE, EMBASE, CENTRAL, ClinicalTrials.gov Study selection. Nine contemporary randomised controlled trials eligible for inclusion enrolling a total of 3325 patients were identified. Follow-up ranged between 1 and 12 months. Data extraction. Data were extracted by two independent reviewers using a standard form and cross-checked. Results. There was suggestive evidence for a reduction in the risk of total mortality in patients undergoing immediate or early PCI. There were no significant differences in the risk of stroke or major bleeding. Conclusions. These results support the current recommendation of a routine early invasive strategy in STEMI patients after successful fibrinolysis.
article type
publisher identifier
  • heartjnl193862
is part of this journal
PubMed ID
  • 20736192



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata